Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertension trial results: consensus and conflicts

C Dollery1

  • 1Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.

Journal of Human Hypertension
|June 1, 1995
PubMed
Summary

Treating mild hypertension in adults under 60 significantly reduces stroke risk by 40%. For older individuals, hypertension treatment offers greater benefits by also lowering coronary events.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigative clinical pharmacology.

Clinical pharmacology and therapeutics·2011
Same author

The future is much closer collaboration between the pharmaceutical industry and academic medical centers.

Clinical pharmacology and therapeutics·2010
Same author

Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training.

Lancet (London, England)·1999
Same author

Human gene for physical performance.

Nature·1998
Same author

ECG and echocardiographic diagnosis of pulmonary thromboembolism associated with central venous lines.

Archives of disease in childhood·1996
Same author

Clinical pharmacology: future prospects for the discipline.

British journal of clinical pharmacology·1996

Area of Science:

  • Cardiology
  • Neurology
  • Public Health

Background:

  • Hypertension management is crucial for preventing cardiovascular and cerebrovascular events.
  • The benefits of treating mild hypertension, particularly in younger populations, require careful evaluation.
  • Declining stroke mortality rates may be influenced by factors beyond hypertension treatment.

Purpose of the Study:

  • To evaluate the benefits of hypertension treatment in different age groups.
  • To quantify the impact of hypertension management on stroke and coronary event reduction.

Main Methods:

  • Analysis of data from clinical trials, including the MRC trial.
  • Assessment of patient-years of treatment required to prevent adverse events.

Main Results:

  • Hypertension treatment reduces stroke by approximately 40% in patients under 60.
  • In older patients, treatment yields greater absolute benefits due to higher event rates and reduction of coronary events.

Conclusions:

  • Hypertension treatment is clearly beneficial in severe and accelerated cases.
  • While beneficial for younger individuals, the number of patients needed to prevent a stroke is substantial.
  • Older patients experience greater absolute benefits from hypertension treatment, including reduced coronary events.

Related Experiment Videos